1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6E787D0821FD48D9265257F1B0043D2CA
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/E787D0821FD48D9265257F1B0043D2CA!OpenDocument
18
19OpenDocument
2035.172.224.102
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Launch Optimization

Document Excerpt: Best Practices and the Role of Medical Affairs in Oncology Launch Excellence

DB Image

ID: MD-490


Features:

14 Info Graphics

12 Data Graphics

100+ Metrics

6 Narratives


Pages/Slides: 4


Published: Pre-2017


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click "
Download Free Excerpt".


To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5389 “Best Practices and the Role of Medical Affairs in Oncology Launch Excellence."


Industries Profiled:
Pharmaceutical; Biopharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Consulting; Health Care; Clinical Research; Laboratories


Companies Profiled:
Astellas; Incyte; Bayer; Insys Therapeutics; Insyght; Jazz Pharmaceuticals; Merck; Onyx Pharmaceuticals; ProStrakan; Roche; Sanofi

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.